Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  1998-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V91.4.1373PMID 9454768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of the Site of Epstein-Barr Virus Persistence In Vivo as a Resting B Cell

  1998cited by this paper
• Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs

  1997cited by this paper
• Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors

  1997cited by this paper
• Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus

  1997cited by this paper
• Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-κB-mediated transcription

  1997cited by this paper
• The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization.

  1996cited by this paper
• Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas.

  1996cited by this paper
• Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

  1996cited by this paper
• Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations.

  1996cited by this paper
• Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.

  1996cited by this paper
• Nasal NK‐ and T‐cell lymphomas share the same type of Epstein‐Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

  1996cited by this paper
• Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.

  1996cited by this paper
• Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas.

  1996cited by this paper
• Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations.

  1996cited by this paper
• Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells

  1996cited by this paper
• CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.

  1996cited by this paper
• Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.

  1996cited by this paper
• Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.

  1995cited by this paper
• Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.

  1995cited by this paper
• Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

  1995cited by this paper
• Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial

  1995cited by this paper
• Epstein‐barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type

  1995cited by this paper
• Identification of a Novel Promoter Located Within the Bam HI Q Region of the Epstein-Barr Virus Genome for the EBNA 1 Gene

  1995cited by this paper
• The investigation of epstein–barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Epidemiologic correlations

  1995cited by this paper
• The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines

  1995cited by this paper
• Burkitt lymphoma cells in expressing EBNA-1 infected with Epstein-Barr virus resembles A subpopulation of normal B cells latently

  1995cited by this paper
• A novel form of Epstein-Barr virus latency in normal B cells in vivo.

  1995cited by this paper
• The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.

  1995cited by this paper
• A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1

  1995cited by this paper
• Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.

  1995cited by this paper
• Structural analyses of the Epstein-Barr virus BamHI A transcripts

  1995cited by this paper
• Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions.

  1994cited by this paper
• An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.

  1994cited by this paper
• Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas.

  1994cited by this paper
• Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.

  1994cited by this paper
• Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

  1994cited by this paper
• Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state

  1994cited by this paper
• Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma.

  1993cited by this paper
• Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors

  1993cited by this paper
• Functions for DNA methylation in vertebrates.

  1993cited by this paper
• Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas

  1993cited by this paper
• Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.

  1993cited by this paper
• Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

  1993cited by this paper
• Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease [published erratum appears in Blood 1993 Oct 1;82(7):2268]

  1993cited by this paper
• The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma.

  1993cited by this paper
• Epstein-Barr Virus and Hodgkin's Disease: Transcriptional Analysis of Virus Latency in the Malignant Cells By E. M. Deacon, G. Pallesen,* G. Niedobitek,~ J. Crocker, g L. Brooks, A. B. Rickinson, and L. S. Young

  1993cited by this paper
• Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease.

  1993cited by this paper
• Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation.

  1993cited by this paper
• Analysis of Epstein-Barr virus gene transcription in lymphoma induced by the virus in the cottontop tamarin by construction of a cDNA library with RNA extracted from a tumour biopsy.

  1993cited by this paper
• Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

  1992cited by this paper
• Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines

  1992cited by this paper
• Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes

  1992cited by this paper
• Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

  1992cited by this paper
• Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas.

  1992cited by this paper
• A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

  1992cited by this paper
• The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle

  1992cited by this paper
• RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types.

  1992cited by this paper
• Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma

  1992cited by this paper
• Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells.

  1992cited by this paper
• The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential

  1992cited by this paper
• Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.

  1992cited by this paper
• Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.

  1992cited by this paper
• Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.

  1992cited by this paper
• Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma.

  1991cited by this paper
• Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.

  1991cited by this paper
• Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.

  1991cited by this paper
• AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

  1991cited by this paper
• Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma [see comments]

  1991cited by this paper
• Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.

  1991cited by this paper
• The pathogenesis of Burkitt's lymphoma.

  1990influential reference
• Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes

  1990cited by this paper
• Detection of a second widespread strain of Epstein-Barr virus.

  1989cited by this paper
• EBV gene expression in an NPC‐related tumour.

  1989cited by this paper
• The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.

  1989cited by this paper
• Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma.

  1988cited by this paper
• Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.

  1988cited by this paper
• New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.

  1987cited by this paper
• Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells

  1987cited by this paper
• Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells.

  1987cited by this paper
• Geographical prevalence of two types of Epstein-Barr virus.

  1986cited by this paper
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

  1985cited by this paper

• LMP2A-The Other EBV Oncogene.

  2025cites this paper
• Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation

  2025cites this paper
• Burkitt's Lymphoma and Early B Cell Transformation as Paradigms of How Epstein-Barr Virus Overcomes Apoptosis and Ferroptosis.

  2025cites this paper
• Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers

  2024cites this paper
• Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis

  2023influential citation
• Comprehensive Profiling of EBV Gene Expression and Promoter Methylation Reveals Latency II Viral Infection and Sporadic Abortive Lytic Activation in Peripheral T-Cell Lymphomas

  2023influential citation
• The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases

  2022cites this paper
• Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis

  2022cites this paper
• Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2

  2022cites this paper
• Methionine Metabolism Controls the B-cell EBV Epigenome and Viral Latency

  2022cites this paper
• Role of Virally Encoded Circular RNAs in the Pathogenicity of Human Oncogenic Viruses

  2021cites this paper
• The importance of microbiota in hematology.

  2021cites this paper
• Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma

  2021cites this paper
• Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus

  2021cites this paper
• CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma.

  2020cites this paper
• CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease

  2020cites this paper
• Non-Hodgkin Lymphoma Epidemiology in Children From 2 Socioeconomic Regions in Mexico: 20-Year Registry (1996-2015)

  2019cites this paper
• Two Pathways of p27Kip1 Degradation Are Required for Murine Lymphoma Driven by Myc and EBV Latent Membrane Protein 2A

  2019cites this paper
• The Possible Role of Gut Microbiota and Microbial Translocation Profiling During Chemo-Free Treatment of Lymphoid Malignancies

  2019cites this paper
• High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments

  2019cites this paper
• Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

  2019cites this paper
• Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma

  2018cites this paper
• Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas

  2018cites this paper
• Multiple cranial nerve palsies in immunodeficiency subtype of Burkitt lymphoma

  2018cites this paper
• Séquençage du génome complet du virus d’Epstein-Barr dans des prélèvements issus de lymphomes T angio-immunoblastiques

  2017cites this paper
• Comprehensive morphological diagnosis of Burkitt's lymphoma

  2017cites this paper
• Systemic Epstein-Barr Virus-positive T-Cell Lymphoproliferative Disease of Childhood With Good Response to Steroid Therapy.

  2017cites this paper
• EBV and Apoptosis: The Viral Master Regulator of Cell Fate?

  2017cites this paper
• Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting.

  2017cites this paper
• Etude des homologies phénotypiques et fonctionnelles des lymphocytes B en latence III de l'EBV avec les cellules B régulatrices, implication de l'axe PD-1/PD-L1

  2017cites this paper
• Epstein–Barr Virus: Diseases Linked to Infection and Transformation

  2016cites this paper
• Early Diagnosis of Burkitt Lymphoma on the Mandible: A Case Report

  2016cites this paper
• Epstein-Barr virus infection of infants: implications of early age of infection on viral control and risk for Burkitt lymphoma.

  2016cites this paper
• Korelasi antara Imunoekspresi LMP-1 Virus Epstein-Barr dengan Respon Kemoterapi CHOP pada Limfoma Maligna Non-Hodgkin Tipe Diffuse Large B Cell.

  2016cites this paper
• Risk factors, etiology, and pathogenesis

  2016cites this paper
• Unexpected patterns of Epstein–Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA

  2015cites this paper
• Latent Membrane Protein 2 (LMP2).

  2015cites this paper
• Burkitt's Lymphoma.

  2015cites this paper
• The human microbiome in hematopoiesis and hematologic disorders.

  2015cites this paper
• Chlorpyrifos Induces the Expression of the Epstein-Barr Virus Lytic Cycle Activator BZLF-1 via Reactive Oxygen Species

  2015cites this paper
• The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases.

  2015cites this paper
• Epstein-Barr Virus Latent Gene Expression in Nasopharyngeal And Gastric Carcinoma

  2015cites this paper
• Identification and characterization of pathogenetically relevant genes in mature aggressive B-cell lymphomas of childhood by a combination of genomic and functional analyses

  2015influential citation
• Study of Epstein-Barr virus expression in Burkitt's lymphoma by polymerase chain reaction and in situ hybridization: A study in Iran

  2014cites this paper
• The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey

  2014influential citation
• Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.

  2014cites this paper
• Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma

  2014cites this paper
• Epstein–Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: Experience of a single institution in Argentina

  2014cites this paper
• Animal Models of Burkitt’s Lymphoma

  2013cites this paper
• PERSISTENCE OF EBV IN THE CANCER STEM CELL FRACTION OF MULTIPLE MYELOMA

  2013cites this paper
• EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS

  2013cites this paper
• Epstein–Barr Virus and Burkitt’s Lymphoma

  2013cites this paper
• Epstein-Barr virus and CNS infectionjs

  2013cites this paper
• Non-Hodgkin Lymphoma of Childhood

  2013cites this paper
• The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection

  2013cites this paper
• Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.

  2012cites this paper
• Burkitt's lymphoma.

  2012cites this paper
• Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature

  2012cites this paper
• Dualité fonctionnelle de LMP1 : implication dans l’apoptose et la transformation cellulaire

  2011influential citation
• Induction of epstein-barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines

  2011cites this paper
• Preclinical Development Rapamycin Reverses Splenomegaly and Inhibits Tumor Development in a Transgenic Model of Epstein-Barr Virus – Related Burkitt ' s Lymphoma

  2011cites this paper
• Epstein-Barr Virus Gene Expression, Human Leukocyte Antigen Alleles and Chronic High Viral Loads in Pediatric Renal Transplant Patients

  2011cites this paper
• miRNAs in the pathogenesis of oncogenic human viruses.

  2011cites this paper
• A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors

  2011cites this paper
• Lymphomas differ in their dependence on Epstein-Barr virus.

  2011cites this paper
• Burkitt's Lymphoma

  2011cites this paper
• Investigating the role of Epstein-Barr virus in the pathogenesis of NK and T cell lymphoproliferations

  2011cites this paper
• Apolipoprotein M Gene (APOM) Polymorphism Modifies Metabolic and Disease Traits in Type 2 Diabetes

  2011cites this paper
• A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.

  2011cites this paper
• Rapamycin Reverses Splenomegaly and Inhibits Tumor Development in a Transgenic Model of Epstein-Barr Virus–Related Burkitt's Lymphoma

  2011cites this paper
• NF-κB as a target for oncogenic viruses.

  2011cites this paper
• Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection.

  2010cites this paper
• Altered Subcellular Localization of c-Myc Protein Identifies Aggressive B-cell Lymphomas Harboring a c-MYC Translocation

  2010cites this paper
• 23Molecular Pathology of Burkitt Lymphoma

  2010cites this paper
• Epstein-Barr virus in Burkitt’s lymphoma: A role for latent membrane protein 2A

  2010cites this paper
• Inhibition du cycle lytique du Virus Epstein-Barr par ARN interférence

  2010cites this paper
• History and Clinical Features of Burkitt Lymphoma 23 The Molecular Pathology of Burkitt Lymphoma

  2010cites this paper
• Insights into the evolution of lymphomas induced by Epstein-Barr virus.

  2010cites this paper
• Epstein–Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b

  2010cites this paper
• History and Clinical Features of Burkitt Lymphoma In 1958

  2010cites this paper
• Epstein–Barr virus LMP2A accelerates MYC-induced lymphomagenesis

  2009cites this paper
• Die Rolle des Epstein-Barr Virus in der Lymphompathogenese

  2009cites this paper
• Epstein-Barr virus BART gene expression.

  2009cites this paper
• Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines

  2009cites this paper
• Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.

  2009cites this paper
• Bilateral mental nerve neuropathy as the sole presenting symptom of Burkitt's Lymphoma.

  2009cites this paper
• The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

  2009cites this paper
• Proof for EBV's sustaining role in Burkitt's lymphomas.

  2009influential citation
• STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro

  2009cites this paper
• Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers

  2009cites this paper
• Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV‐associated disease

  2008cites this paper
• Novel virally targeted therapies of EBV-associated tumors.

  2008cites this paper
• One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.

  2008cites this paper
• Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential

  2008cites this paper
• Regulation and dysregulation of Epstein–Barr virus latency: Implications for the development of autoimmune diseases

  2008cites this paper
• An auto-regulatory loop for EBV LMP2A involves activation of Notch.

  2008influential citation
• Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1

  2008cites this paper
• EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.

  2008cites this paper
• Intraocular Lymphoproliferations Simulating Uveitis

  2008cites this paper
• Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.

  2007cites this paper